Statistics
Total Visits
Views | |
---|---|
Effectiveness and safety of sofosbuvir‐based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis: results of a multicenter real‐life cohort | 135 |
Total Visits Per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Effectiveness and safety of sofosbuvir‐based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis: results of a multicenter real‐life cohort | 0 | 7 | 2 | 2 | 2 | 0 | 3 | 2 | 1 | 7 | 12 |
File Visits
Views | |
---|---|
Also_Effctvness.pdf | 181 |
Top country views
Views | |
---|---|
United States | 59 |
Sweden | 20 |
Germany | 14 |
Spain | 5 |
Ukraine | 5 |
China | 4 |
France | 3 |
Ireland | 3 |
Vietnam | 3 |
Belgium | 1 |
Top cities views
Views | |
---|---|
Menlo Park | 8 |
Louisville | 7 |
Ashburn | 5 |
Boardman | 5 |
Jacksonville | 5 |
Mountain View | 5 |
San Mateo | 5 |
Fremont | 4 |
Dublin | 3 |
Hangzhou | 3 |